{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:16:21Z","timestamp":1787238981646,"version":"build-2736575974"},"reference-count":139,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":5344,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.anpedi.2011.10.008","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T18:28:53Z","timestamp":1324060133000},"page":"43.e1-43.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunization schedule of the Spanish Association of Pediatrics: 2012 recommendations"],"prefix":"10.1016","volume":"76","author":[{"given":"D.","family":"Moreno-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"\u00c1lvarez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Aristegui Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barrio Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Cilleruelo Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Corretger Rauet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gonz\u00e1lez-Hachero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hern\u00e1ndez-Sampelayo Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Merino Mo\u00edna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ortigosa del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2011.10.008_bib0005","doi-asserted-by":"crossref","first-page":"132.e1","DOI":"10.1016\/j.anpedi.2010.10.004","article-title":"Vaccination schedule of the Spanish Association of Paediatrics: recommendations 2011","volume":"74","author":"Mar\u00e8s Berm\u00fadez","year":"2011","journal-title":"Ann Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0010","unstructured":"Immunisation schedules in Spain. Available at: http:\/\/www.aepap.org\/vacunas\/calvaces.htm [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0015","first-page":"1","article-title":"Recommended immunization schedules for persons aged 0\u201318 years \u2013 United States, 2011","volume":"60","year":"2011","journal-title":"MMWR"},{"issue":"No.RR-16","key":"10.1016\/j.anpedi.2011.10.008_bib0020","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1. Immunization of infants, children, and adolescents","volume":"54","year":"2005","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000227725.61495.c4","volume":"25","author":"Tejedor","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-2","key":"10.1016\/j.anpedi.2011.10.008_bib0030","first-page":"1","article-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP). Recommendations and reports","volume":"60","year":"2011","journal-title":"MMRW"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/11206990-000000000-00000","article-title":"Spotlight on Tdap5 vaccine (Covaxis\u00ae) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertusis in children (aged = o > 4 years), adolescents, and adults","volume":"13","author":"Scott","year":"2011","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0040","first-page":"13","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertusis (Tdap) vaccine from the Advisory Committee on the Immunization Practices (ACIP), 2010","volume":"60","year":"2011","journal-title":"MMRW"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(11)70007-X","article-title":"Rationale for pertussis booster vaccination throughout life in Europe","volume":"11","author":"Zepp","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0050","unstructured":"Substitution of the Tdap for the DTaP for the fifth booster dose. Purpose to the National Public Health Committee. Report of the Vaccination Registry and Programme of the National Health Service. Madrid (Spain), February 16, 2010. Available at: http:\/\/www.aragon.es\/estaticos\/GobiernoAragon\/Departamentos\/SaludConsumo\/Profesionales\/13_SaludPublica\/20_Programas_Salud\/Propuesta_recomendacion_sustitucion_vacuna_DTPa.pdf [accessed October 12, 2011]."},{"issue":"RR-03","key":"10.1016\/j.anpedi.2011.10.008_bib0055","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMRW"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0060","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/INF.0b013e3181ea5866","article-title":"Reactogenicity of tetanus, diphtheria, 5 component acellular pertusis vaccine administered as sixth consecutive acellular pertusis vaccine dose to adolescents","volume":"29","author":"Liese","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/hv.4.3.5290","article-title":"Immunogenicity and reactogenicity of acellular pertusis booster vaccines in children","volume":"4","author":"Meyer","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertusis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0075","unstructured":"Wolters Kluwer-Pharma Solutions. Drugs perspectives in vaccinology. Bortedella pertussis: Is there a need for expanded immunization programme? Science Communications, Rueil-Malmaison Cedex-France; 2011:1\u201318."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0080","unstructured":"Immunization in adults. Tetanus and diphtheria immunization recommendations, 2009. Available at: http:\/\/www.msps.es\/ciudadanos\/proteccionSalud\/vacunaciones\/docs\/TetanosDifteria_2009.pdf [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0085","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1086\/426020","article-title":"New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative","volume":"39","author":"Forsyth","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cid\/ciq001","article-title":"Implementation of cocooning against pertussis in a high-risk population","volume":"52","author":"Healy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0095","unstructured":"Conseil Sup\u00e9rieur de la Sant\u00e9. Vaccination anticoquelucheuse (fichier 8547). Vaccination de \u013aadulte (2009). Available at: http:\/\/www.belgium.be\/en\/health\/ [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0100","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0105","unstructured":"Epidemiological national surveillance system. Meningococcal disease in Spain. Analysis of the 2003\u20132004 season. Madrid, May 2005. Available at: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/boletines.shtml [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0110","unstructured":"Public Health and Food System of the Comunidad de Madrid. Bacterial meningitis, 2005. Available at: http:\/\/www.madrid.org\/cs\/Satellite?pagename=PortalSalud\/Page\/PTSA_home [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0115","unstructured":"Meningococcal Disease Group. Current status of the meningococcal disease in Spain. Modification of the vaccination schedule against meningococcal C. Available at: http:\/\/www.msc.es\/ciudadanos\/proteccionSalud\/infancia\/docs\/MenC_MARZO_2006.pdf [accessed October 12, 2011]."},{"issue":"Suppl 2","key":"10.1016\/j.anpedi.2011.10.008_bib0120","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: the experience in England and Wales","volume":"27","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated post licensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0130","unstructured":"Carlos III Institute, National Epidemiological Surveillance Net. Epidemiological Weekly Bulletin. Meningococcal disease information 37\/2011. Available at: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/boletines.html [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0135","unstructured":"Menveo\u00ae (Novartis). Ficha t\u00e9cnica. Available at: www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/001095\/WC500090147.pdf [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0140","unstructured":"European Centre for Disease Control and Prevention (ECDC). Measles. Available at: http:\/\/www.ecdc.europa.eu\/en\/healthtopics\/measles\/Pages\/index.aspx [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0145","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Eliminaci\u00f3n del Sarampi\u00f3n. Gu\u00eda Pr\u00e1ctica 2.a Edici\u00f3n. Publicaci\u00f3n cient\u00edfica y t\u00e9cnica, n.\u00b0 605. Washington: OMS; 2007."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0150","series-title":"Measles. In: Manual of childhood infections. The blue book. 3a Edici\u00f3n","first-page":"624","year":"2011"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0155","unstructured":"Consejer\u00eda de Salud de la Junta de Andaluc\u00eda. Secretar\u00eda General de Salud P\u00fablica y Participaci\u00f3n: Servicio de Vigilancia Epidemiol\u00f3gica de Andaluc\u00eda. Protocolo de Alerta Epidemiol\u00f3gica por Sarampi\u00f3n-adaptado. \u00daltima modificaci\u00f3n de 24 de Abril del 2008. Sevilla; 2011."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0160","unstructured":"Calendario de vacunaciones del Consejo Interterritorial del Sistema Nacional de Salud 2007. Available at: http:\/\/www.msps.es\/ciudadanos\/proteccionSalud\/infancia\/docs\/c2007.pdf [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0165","unstructured":"Ficha t\u00e9cnica de Gardasil\u00ae (EPAR, \u00faltima actualizaci\u00f3n: 14 de septiembre de 2011). Available at: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000703\/human_med_000805.jsp&mid=WC0b01ac058001d124 [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0170","unstructured":"Ficha t\u00e9cnica de Cervarix\u00ae (EPAR, \u00faltima actualizaci\u00f3n: octubre de 2010). Available at: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000721\/human_med_000694.jsp&mid=WC0b01ac058001d124 [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0175","unstructured":"Ficha t\u00e9cnica Gardasil\u00ae (FDA, \u00faltima actualizaci\u00f3n: 22 de diciembre de 2010). Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm237941.htm [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0180","first-page":"630","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0185","series-title":"26th international papillomavirus conference","article-title":"Efficacy of the HPV-16\/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types: end of study results","author":"Romanowski","year":"2011"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0190","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/INF.0b013e3181c177fb","volume":"29","author":"Vesikari","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0195","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1097\/INF.0b013e31822d28df","volume":"30","author":"Wheeler","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-11-13","article-title":"Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis","volume":"11","author":"Lu","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0205","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2010.02.019","article-title":"Post-licensure monitoring of HPV vaccine in the United States","volume":"28","author":"Markowitz","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0210","first-page":"325","article-title":"Global Advisory Committee on Vaccine Safety, report of meeting held 17\u201318 June 2009","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl. 4","key":"10.1016\/j.anpedi.2011.10.008_bib0215","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jadohealth.2010.01.010","article-title":"Human papillomavirus-related disease in men: not just a women's issue","volume":"46","author":"Palefsky","year":"2010","journal-title":"J Adolesc Health"},{"issue":"August","key":"10.1016\/j.anpedi.2011.10.008_bib0220","article-title":"The cost-effectiveness of male HPV vaccination in the United States","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0225","unstructured":"Web de la Agencia Europea de Medicamentos. Ficha t\u00e9cnica de Synflorix (\u00faltima actualizaci\u00f3n: 16 de agosto de 2011). Available at: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000973\/human_med_001071.jsp&mid=WC0b01ac058001d124 [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0230","unstructured":"Web de la Agencia Europea de Medicamentos. Ficha t\u00e9cnica de Prevenar13 (\u00faltima actualizaci\u00f3n: 09 de diciembre de 2009). Available at: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/001104\/WC500057247.pdf [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CVI.00317-10","article-title":"Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar","volume":"18","author":"Picazo","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jinf.2011.06.002","article-title":"Serotypes and clones causing invasive pneumococccal disease before the use of new conjugate vaccines in Catalonia, Spain","volume":"63","author":"Mu\u00f1oz-Almagro","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0245","series-title":"29th annual meeting of European Society for Pediatric Infectious Diseases (ESPID)","article-title":"Distribution by clinical presentation of serotypes isolated from pediatric invasive pneumococcal diseases in 2009\u20132010, Madrid, Spain","author":"Picazo","year":"2011"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0250","unstructured":"Conselleria de Sanitat de la Generalitat Valenciana. Direcci\u00f3 General de Salut P\u00fablica. Informe de Enfermedad neumoc\u00f3cica invasora 2008. Available at: http:\/\/www.san.gva.es\/cas\/prof\/homeprof.html [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0255","series-title":"29th annual meeting of European Society for Paediatric Infectious Diseases (ESPID)","article-title":"The Heracles study (2007\u20132010): a prospective hospital-based surveillance of serotypes causing pediatric invasive pneumococcal disease in Madrid, Spain","author":"Picazo","year":"2011"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0260","series-title":"29th annual meeting of European Society for Paediatric Infectious Diseases (ESPID)","article-title":"Distribution by age of serotypes isolated from pediatric invasive pneumococcal diseases in 2009\u20132010 in Madrid, Spain","author":"Picazo","year":"2011"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0265","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1469-0691.2011.03526.x","article-title":"Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989\u20132008)","volume":"17","author":"Esteva","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0270","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/INF.0b013e31820a418a","article-title":"Laboratory-based, 2-year surveillance of pediatric parapneumonic empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid","volume":"30","author":"Picazo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0275","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pneumococcal serotypes in children in 4 European countries","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0280","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1128\/AAC.00217-10","article-title":"Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008","volume":"54","author":"Fenoll","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0285","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2009.05.012","article-title":"Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona","volume":"59","author":"Mu\u00f1oz-Almagro","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0290","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.vaccine.2010.12.114","article-title":"Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007\u20132009) laboratory-based surveillance in Madrid","volume":"29","author":"Picazo","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0295","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/AAC.01494-10","article-title":"Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008","volume":"55","author":"Tarrag\u00f3","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0300","series-title":"29th annual meeting of European Society for Paediatric Infectious Diseases (ESPID)","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Alaska native children: results of a clinical trial","author":"Singleton","year":"2011"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0305","unstructured":"Health Protection Agency (HPA). Current epidemiology of invasive pneumococcal disease. Available at: http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/Pneumococcal\/EpidemiologicalDataPneumococcal\/CurrentEpidemiologyPneumococcal\/ [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0310","series-title":"51st interscience conference on antimicrobial agents and chemotherapy (ICAAC)","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old, U.S., 2010","author":"Moore","year":"2011"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0315","series-title":"Interscience conference on antimicrobial agents and chemotherapy (ICAAC)","article-title":"Evolution of Streptococcus pneumoniae serotypes following introduction of the 13-valent conjugate pneumococcal vaccine","author":"Jacobs","year":"2011"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0320","series-title":"51st interscience conference on antimicrobial agents and chemotherapy (ICAAC)","article-title":"Impact of 13-valent pneumococcal conjugate vaccine (PCV13) on nasopharyngeal (NP) flora in children with acute otitis media (AOM)","author":"Cohen","year":"2011"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0325","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0330","series-title":"27th annual meeting of the European Society for Paediatric Infectious Disease (ESPID)","article-title":"Immunogenicity of booster doses of 13-valent pneumococcal conjugate and Hib\/MenC vaccines given at 12 months of age in the UK","author":"Hughes","year":"2009"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0335","unstructured":"Actualizaci\u00f3n en vacunaci\u00f3n antineumoc\u00f3cica. Recomendaciones del Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Available at: http:\/\/vacunasaep.org\/documentos\/actualizacion-en-vacunacion-antineumococica-2010-recomendaciones-del-comite-asesor-de-vac [accessed October 12, 2011]."},{"issue":"RR11","key":"10.1016\/j.anpedi.2011.10.008_bib0340","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children \u2013 use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0345","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/INF.0b013e3181bbf2a0","article-title":"Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella","volume":"29","author":"Shah","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0350","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/522146","article-title":"Epidemiology of varicella hospitalizations in the United States, 1995\u20132005","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0355","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0360","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0365","unstructured":"Comit\u00e9 Asesor de Vacunas de la Comunidad de Madrid. Servicio Madrile\u00f1o de Salud. Informe sobre varicela en la Comunidad de Madrid; 2010. Available at: http:\/\/www.madrid.org\/cs\/Satellite?language=es&pagename=PortalSalud%2FPage%2FPTSA_home [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0370","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4321\/S1137-66272011000200006","article-title":"Impacto de la vacunaci\u00f3n universal frente a la varicela en Navarra, 2006\u20132010","volume":"34","author":"Garc\u00eda Cenoz","year":"2011","journal-title":"An Sist Sanit Navar"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0375","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1542\/peds.113.3.455","article-title":"Chickenpox outbreak in highly vaccinated school population","volume":"113","author":"Tugwell","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0380","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2007.07.010","article-title":"Metaanalysis of vaccine effectiveness in varicella outbreaks","volume":"25","author":"Bayer","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0385","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella vaccine over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0390","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons. Clinical and epidemiological characteristics, 1997\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0395","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0400","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J Infect Dis"},{"issue":"RR-4","key":"10.1016\/j.anpedi.2011.10.008_bib0405","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0410","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1542\/peds.2007-1089","article-title":"Committee on Infectious Diseases. Prevention of varicella: recommendations for use of varicella vaccines in children, including recommendations for a routine 2-dose varicella immunization schedule","volume":"120","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0415","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/522130","article-title":"Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine","volume":"197","author":"Watson","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0420","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"Brisson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0425","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/591975","article-title":"Herpes zoster-related hospitalization and expenditures before and after introduction on the varicella vaccine in the United States","volume":"29","author":"Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0430","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.vaccine.2010.01.036","article-title":"A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia","volume":"28","author":"Carville","year":"2010","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.anpedi.2011.10.008_bib0435","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/522162","article-title":"The impact of the varicella vaccination program on herpes zoster epidemiology in the United States a review","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0440","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2796.2011.02359.x","article-title":"Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia","volume":"259","author":"Gilden","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0445","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3201\/eid1202.050006","article-title":"Rotavirus and severe childhood diarrhea","volume":"12","author":"Parashar","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0450","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/INF.0b013e3181967bee","article-title":"Rotavirus overview","volume":"28","author":"Bernstein","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-2","key":"10.1016\/j.anpedi.2011.10.008_bib0455","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"58","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0460","first-page":"1146","article-title":"Reduction in rotavirus after vaccine introduction \u2013 United States, 2000\u20132009","volume":"58","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0465","first-page":"533","article-title":"Rotavirus vaccines: an update","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0470","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1016\/j.vaccine.2010.09.013","article-title":"Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA","volume":"28","author":"Desai","year":"2010","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.anpedi.2011.10.008_bib0475","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/INF.0b013e3181ffe3eb","article-title":"Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006","volume":"30","author":"Tate","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0480","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/j.vaccine.2011.03.035","article-title":"Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhoea: the IVANHOE study","volume":"29","author":"Gagneur","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.anpedi.2011.10.008_bib0485","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/INF.0b013e3181fefb32","article-title":"Impact of rotavirus vaccination on diarrhea-related hospitalizations among children <5 years of age in Mexico","volume":"30","author":"Quintanar-Solares","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0490","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa0905211","article-title":"Effect of rotavirus vaccination on death from childhood diarrhea in Mexico","volume":"362","author":"Richardson","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.anpedi.2011.10.008_bib0495","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/INF.0b013e3181fefdee","article-title":"Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule","volume":"30","author":"Buttery","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0500","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1542\/peds.2010-1830","article-title":"Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children","volume":"127","author":"Anderson","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0505","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1000446","article-title":"Rotavirus vaccine and health care utilization for diarrhea in U.S. children","volume":"365","author":"Cortes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0510","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4161\/hv.7.7.15576","article-title":"Effectiveness of rotavirus vaccination in Spain","volume":"7","author":"Martin\u00f3n-Torres","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0515","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.vaccine.2011.01.104","article-title":"Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria","volume":"29","author":"Paulke-Korinek","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.anpedi.2011.10.008_bib0520","first-page":"38","article-title":"Hepatology, and nutrition evidence-based recommendations for rotavirus vaccination in Europe","volume":"46","author":"Vesikari","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0525","first-page":"66","article-title":"Safety of rotavirus vaccines: postmarketing surveillance in the WHO Region of the Americas","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0530","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.anpedi.2011.10.008_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0b013e3181fefa1f","article-title":"Real-world impact of rotavirus vaccination","volume":"30","author":"Patel","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0540","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.02690-09","article-title":"Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus","volume":"84","author":"Victoria","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0545","unstructured":"Rotavirus vaccination \u2013 WHO does not recommend any change to use of Rotarix vaccine. Available at: http:\/\/www.who.int\/immunization\/newsroom\/news_rotavirus_vaccine_use\/en\/index.html [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0550","unstructured":"FDA revises recommendations for rotavirus vaccines. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2010\/ucm212149.htm [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0555","unstructured":"European Medicines Agency confirms positive benefit-risk balance of Rotarix. Porcine circovirus type 1 in the oral vaccine poses no risk to public health. Available at: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2010\/07\/news_detail_001059.jsp&murl=menus\/news_and_events\/news_and_events.jsp&mid=WC0b01ac058004d5c1&jsenabled=true [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0560","unstructured":"European Medicines Agency confirms positive benefit-risk balance of RotaTeq. Available at: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2010\/09\/news_detail_001121.jsp&murl=menus\/news_and_events\/news_and_events.jsp&mid=WC0b01ac058004d5c1&jsenabled=true [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0565","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.vaccine.2010.11.028","article-title":"Analysis of porcine circovirus type 1 detected in Rotarix vaccine","volume":"29","author":"Baylis","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0570","unstructured":"Detecci\u00f3n de ADN de circovirus porcino en las vacunas frente a rotavirus: Rotarix\u00ae y RotaTeq\u00ae. Documento de consenso de las sociedades cient\u00edficas AEP, AEV, SEIP y SEGHNP. Actualizaci\u00f3n del 3 de diciembre de 2010. Available at: http:\/\/vacunasaep.org\/sites\/vacunasaep.org\/files\/Vac_RV_AEP_AEV_SEIP_SEGHNP_dic-2010_3.pdf [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0575","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0580","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0585","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0590","first-page":"317","article-title":"Rotavirus vaccine and intussusception: report from an expert consultation","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0595","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1056\/NEJMe1105302","article-title":"Rotavirus vaccination and intussusception-act two","volume":"364","author":"Greenberg","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0600","unstructured":"Nota informativa: Liberaci\u00f3n de lotes de la vacuna Rotateq\u00ae. AEMPS, 4 noviembre 2010. Available at: http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/calidad\/2010\/NI-circovirus-rotateq_noviembre-2010.htm [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0700","doi-asserted-by":"crossref","first-page":"44.e1","DOI":"10.1016\/j.anpedi.2011.09.010","article-title":"Vacunaci\u00f3n frente a la gripe estacional en la infancia y la adolescencia. Recomendaciones del CAV-AEP para la campa\u00f1a 2011-2012","volume":"76","author":"Moreno-P\u00e9rez","year":"2012","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0610","unstructured":"World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2011\u20132012 northern hemisphere influenza season OMS. Available at: http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/2011_09_recommendation.pdf [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0615","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1016\/j.vaccine.2011.08.010","article-title":"Seasonal influenza: the burden of disease in children","volume":"29","author":"Fraaij","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0620","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1743-422X-8-349","article-title":"Viral shedding in children infected by pandemic A\/H1N1\/2009 influenza virus","volume":"8","author":"Esposito","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0625","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/INF.0b013e3181fe37c8","article-title":"Incidence of influenza-related hospitalizations in different age groups of children in Finland: a 16-year study","volume":"30","author":"Silvennoinen","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0630","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The underrecognized burden of influenza in young children","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0635","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children","author":"Jefferson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0640","unstructured":"Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR. 2011;60. Available at: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6033a3.htm?s_cid=mm6033a3_w [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0645","unstructured":"Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Fichas t\u00e9cnicas de vacunas antigripales. Available at: http:\/\/vacunasaep.org\/profesionales\/fichas-tecnicas-vacunas\/resultados?diseases=148 [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0650","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2007-1088","article-title":"Committee on Infectious Diseases. Hepatitis A vaccine recommendations","volume":"120","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0655","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0264-410X(02)00583-2","article-title":"Effectiveness of a mass hepatitis A vaccination program in preadolescents","volume":"21","author":"Dom\u00ednguez","year":"2003","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.anpedi.2011.10.008_bib0660","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2893.2008.01030.x","article-title":"Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain","volume":"15","author":"Dom\u00ednguez","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0665","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.vaccine.2008.01.048","article-title":"Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction","volume":"26","author":"Dom\u00ednguez","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0670","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1576-9887(09)71384-6","article-title":"Vacunaci\u00f3n antihepatitis A: \u00bfselectiva o universal?","volume":"10","author":"Rodr\u00edguez","year":"2009","journal-title":"Vacunas"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0675","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1586\/erv.11.3","article-title":"Challenges for development of meningococcal vaccines in infants and children","volume":"10","author":"Deasy","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0680","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/erv.11.32","article-title":"A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease","volume":"10","author":"Su","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0685","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/erv.11.41","article-title":"Meningococcal serogroup B vaccines: will they live up to expectations?","volume":"10","author":"Zollinger","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.anpedi.2011.10.008_bib0690","unstructured":"Centers for Disease Control and Prevention (CDC). Catch-up immunization schedule for persons aged 4 months to 18 years who start late or who are more than 1 month behind. Available at: http:\/\/www.cdc.gov\/vaccines\/recs\/schedules\/downloads\/child\/catchup-schedule-pr.pdf [accessed October 12, 2011]."},{"key":"10.1016\/j.anpedi.2011.10.008_bib0695","unstructured":"The Australian Immunization Handbook, 9th Edition, 2008. Catch-up \u2013 updated July 2009. Available at: http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/handbook-catchup [accessed October 12, 2011]."}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S169540331100542X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S169540331100542X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:32:56Z","timestamp":1787106776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S169540331100542X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S169540331100542X"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2011.10.008","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization schedule of the Spanish Association of Pediatrics: 2012 recommendations","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2011.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2011.10.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}